Catalyst Wire Dossier Catalyst Wire Dossier

Peg-IFN-Alpha-2A (Pegasys)

pegylated interferon alfa-2a · Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Peg-IFN-Alpha-2A (Pegasys), covering 2015-02-10 to 2015-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection [Phase 2]

See pricing